Terms: = Gastric cancer AND ERG, P11308, 2078 AND Treatment
10 results:
1. Synchronous Double Primary Angiosarcoma Originating from the Stomach and Rectum: A Case Report and a Literature Review.
Kapagan T; Bulut N; Erdem GU; Yıldırım S; Erdem ZB; Sahin H
Arch Iran Med; 2024 Mar; 27(3):168-173. PubMed ID: 38685842
[TBL] [Abstract] [Full Text] [Related]
2. Analysis of Prognostic Risk Factors of Endoscopic Submucosal Dissection (ESD) and Curative Resection of Gastrointestinal Neuroendocrine Neoplasms.
Si Y; Huang C; Yuan J; Zhang X; He Q; Lin Z; He L; Liu Z
Contrast Media Mol Imaging; 2022; 2022():5248256. PubMed ID: 35854772
[TBL] [Abstract] [Full Text] [Related]
3. The transformation of isolated gastric myeloid sarcoma into acute myeloid leukemia presenting with a complex karyotype and TLS-erg gene fusion: A case report.
Gao L; Xu Y; Tian Z; Xia J; Yuan Z; Chen D; Ren M
Medicine (Baltimore); 2022 May; 101(21):e29475. PubMed ID: 35623083
[TBL] [Abstract] [Full Text] [Related]
4. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
Naderi A
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
[TBL] [Abstract] [Full Text] [Related]
5. Diffusion kurtosis imaging in the prediction of poor responses of locally advanced gastric cancer to neoadjuvant chemotherapy.
Fu J; Tang L; Li ZY; Li XT; Zhu HF; Sun YS; Ji JF
Eur J Radiol; 2020 Jul; 128():108974. PubMed ID: 32416553
[TBL] [Abstract] [Full Text] [Related]
6. The poor prognosis of the primary gastric epithelioid angiosarcoma: A case report.
Xia J; Shi D; Wu Z; Chen Y; Liu B; Chen L; Metta W; Zheng Y
Medicine (Baltimore); 2018 Apr; 97(15):e0287. PubMed ID: 29642150
[TBL] [Abstract] [Full Text] [Related]
7. Intravenous iron supplementation may be superior to observation in acute isovolemic anemia after gastrectomy for cancer.
Yoon HM; Kim YW; Nam BH; Reim D; Eom BW; Park JY; Ryu KW
World J Gastroenterol; 2014 Feb; 20(7):1852-7. PubMed ID: 24587663
[TBL] [Abstract] [Full Text] [Related]
8. Trastuzumab for the treatment of HER2-positive metastatic gastric cancer : a NICE single technology appraisal.
Spackman E; Rice S; Norman G; Suh DC; Eastwood A; Palmer S
Pharmacoeconomics; 2013 Mar; 31(3):185-94. PubMed ID: 23371465
[TBL] [Abstract] [Full Text] [Related]
9. Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.
Norman G; Rice S; Spackman E; Stirk L; Danso-Appiah A; Suh D; Palmer S; Eastwood A
Health Technol Assess; 2011 May; 15 Suppl 1():33-42. PubMed ID: 21609651
[TBL] [Abstract] [Full Text] [Related]
10. Capecitabine for the treatment of advanced gastric cancer.
Norman G; Soares M; Peura P; Rice S; Suh D; Wright K; Sculpher M; Eastwood A
Health Technol Assess; 2010 Oct; 14(Suppl. 2):11-7. PubMed ID: 21047486
[TBL] [Abstract] [Full Text] [Related]
